As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...

Highly effective treatments for HIV have existed since the mid-1990s. But while these treatments keep people healthy, we do not yet have a safe and scalable way to completely rid the body of the virus ...

These drugs may help prevent HIV transmission. If you received a diagnosis of HIV, carefully following your treatment plan is ...

Babies getting HIV from their infected mothers is a rare occurrence in a cluster of 39 villages in the OR Tambo District in ...

As part of our coverage of the biennial AIDS conference from the International AIDS Society, we spoke with Madalitso Juwayeyi, program manager at FACT-Malawi, to learn more about her organization and ...

In this article, we will take a look at the 10 Best Pharma Stocks To Buy Right Now.

Boksburg North Clinic has recently been awarded first place for the best yield and case finding ... s outstanding performance and commitment to HIV treatment and awareness.

Gilead Sciences ( GILD) increased its growth forecast for the year on strong third quarter results, marking a shift away from ...

Historical treatment plans are still extremely important in guiding future treatment decisions, however, it is critical that we do more with the data in real time, to ensure the best possible outcomes ...

Johnson & Johnson announced that the China National Medical Products Administration has approved Teclistamab Injection as a ...

Oppenheimer raised the firm’s price target on Gilead (GILD) to $105 from $95 and keeps an Outperform rating on the shares. The firm ...